ADVERTISEMENT
Dr Schadendorf Discusses C.A.S.E. Study in CSCC; Current Treatment Changes
10/06/2020
Dirk Schadendorf, MD, Department of Dermatology and the West German Cancer Center (WTZ) at the University Hospital Essen, discusses demographics, prior therapies and reasons for cemiplimab treatment for CSCC, and more.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement